ALGN
HealthcareAlign Technology, Inc. · Medical - Devices · $12B
What is Align Technology, Inc.?
Align Technology is a large-cap medical device company best known for Invisalign clear aligners, which have reshaped how orthodontists and dentists approach teeth straightening. Headquartered in Tempe, Arizona, the company also develops digital scanning technology used across dental practices worldwide.
Align Technology operates through two segments. The Clear Aligner segment produces Invisalign products targeting patients from young children to adults, including comprehensive and non-comprehensive treatment options, retention products, and ancillary dental tools. The Scanners and Services segment offers the iTero intraoral scanner platform, which supports both restorative and orthodontic workflows, along with software for digital records, diagnosis, and model fabrication. Revenue flows primarily from case submissions by dental professionals and scanner sales.
Align Technology was founded in 2001 and is headquartered in Tempe, Arizona.
- Invisalign comprehensive clear aligner treatments for teens and adults
- Invisalign First packages designed for younger pediatric patients
- Invisalign moderate, lite, and express non-comprehensive options
- iTero intraoral scanners with restorative and orthodontic software
- Retention products and ancillary dental professional tools
Is ALGN a Good Stock to Buy?
UQS Score rates ALGN as Good overall, reflecting a balanced but nuanced profile across its five quality pillars.
The Risk pillar stands out as the clearest positive — ALGN carries a Strong rating there, suggesting the business is not exposed to the kinds of balance-sheet or operational vulnerabilities that concern investors in the medical device space. The Valuation pillar also earns a Good label, meaning the stock does not appear significantly stretched relative to its fundamentals.
Growth is rated Weak, pointing to a period of slower expansion, while both Quality and Moat sit at Neutral — indicating the business has defensible characteristics but has not yet demonstrated the kind of durable competitive dominance that commands a premium rating.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does ALGN pay dividends?
No — Align Technology, Inc. does not currently pay a dividend.
Align Technology does not currently pay a dividend. For a growth-oriented medical device company, this is typical — capital tends to be reinvested into product development, geographic expansion, and platform enhancements rather than returned to shareholders as income. Investors seeking yield may want to factor this into their portfolio planning.
When does ALGN report earnings?
Align Technology reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's Growth pillar is currently rated Weak, which suggests recent quarters have reflected softer top-line momentum relative to historical norms. Investors tracking results should watch for commentary on case volume trends and scanner adoption across geographies.
For the most recent quarter's results and guidance, visit Align Technology's investor relations page directly.
ALGN Price History
-66.9% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Align Technology, Inc.?
Based on Align Technology, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
ALGN Long-term Outlook
With a Weak Growth rating, ALGN's near-term trajectory appears constrained — the business is navigating a period where volume recovery and market penetration are key variables. The Strong Risk profile provides some reassurance that the company is not taking on outsized financial exposure during this slower phase. A Good Valuation label suggests the market has already adjusted expectations to some degree, which may limit downside if fundamentals stabilize.
Growth drivers
- Expanding Invisalign adoption among general practitioner dentists globally
- iTero scanner platform deepening digital workflow integration in dental practices
- Younger patient segments (Invisalign First) opening new orthodontic addressable markets
Key risks
- Sustained weakness in case volume growth across key markets
- Competitive pressure from lower-cost clear aligner alternatives
- Macroeconomic sensitivity — elective dental spending can decline in downturns
ALGN vs Peers
Align Technology competes broadly within the medical device landscape, though its clear aligner and intraoral scanning focus gives it a distinct niche compared to most device peers.
Penumbra focuses on neurovascular and peripheral vascular intervention devices, operating in a very different clinical segment from Align's dental and orthodontic focus.
Insulet develops tubeless insulin delivery systems for diabetes management, representing a chronic-disease device model distinct from Align's elective orthodontic market.
Globus Medical specializes in musculoskeletal solutions including spine and orthopedic implants, competing for capital allocation within the broader medical device sector.
Frequently Asked Questions
What does Align Technology do?
Align Technology designs and manufactures Invisalign clear aligners and iTero intraoral scanners. Its products are used by orthodontists and dentists to plan and deliver teeth-straightening treatments digitally. The company serves patients ranging from young children to adults through a range of comprehensive and non-comprehensive aligner packages.
Does ALGN pay dividends?
No, Align Technology does not currently pay a dividend. The company reinvests available capital into product development and market expansion rather than distributing income to shareholders. Investors focused on dividend income should note this when evaluating ALGN.
When does ALGN report earnings?
Align Technology follows a standard quarterly earnings schedule. The exact dates for upcoming reports are published on the company's investor relations page, which is the most reliable source for confirmed release times and webcast details.
Is ALGN a good stock to buy?
UQS Score rates ALGN as Good overall. The stock shows a Strong Risk profile and a Good Valuation label, which are positives. However, the Growth pillar is rated Weak and both Quality and Moat are Neutral, suggesting a mixed picture. The full pillar breakdown is available to UQS Pro members.
Is ALGN overvalued?
Based on the UQS Valuation pillar, ALGN currently carries a Good label — meaning the stock does not appear significantly overpriced relative to its fundamentals. This suggests the market has calibrated expectations to reflect the company's current growth environment. Full valuation metrics are available in the Pro view.
How does ALGN compare to its competitors?
Align Technology occupies a specialized niche in dental and orthodontic devices, which differentiates it from peers like Penumbra (neurovascular), Insulet (diabetes management), and Globus Medical (spine and orthopedics). Side-by-side UQS pillar comparisons for these tickers are available on their respective pages.
What is ALGN's market cap bracket?
Align Technology is classified as a large-cap company. This places it among the more established players in the medical device sector, with the scale and resources to invest in global market development and ongoing product innovation.
Who founded Align Technology?
Align Technology was founded in 2001. Founding details, including the names of original co-founders, are widely available through the company's official history and public filings for those researching the company's origins.
Is ALGN a long-term quality indicator?
As a long-term quality indicator, ALGN's UQS profile is mixed. The Strong Risk rating and Good Valuation suggest a degree of financial stability, but the Weak Growth and Neutral Moat ratings indicate the company needs to demonstrate renewed competitive strength over time. Pro members can view the complete pillar trend analysis.
What is the main competitive advantage of Align Technology?
Align Technology's primary advantage lies in the Invisalign brand's deep penetration among orthodontists and the integration of its iTero scanning platform into dental workflows. However, the UQS Moat pillar currently rates this advantage as Neutral, reflecting competitive pressure from alternative clear aligner providers.
What sector does ALGN belong to?
Align Technology is classified within the Healthcare sector, specifically in the medical device industry. Its products sit at the intersection of orthodontics and digital dentistry, making it a somewhat unique name within the broader healthcare device universe.
Is ALGN a growth stock or value stock?
Based on UQS pillar labels, ALGN leans toward value characteristics at present — the Valuation pillar is rated Good while Growth is rated Weak. This suggests the stock may appeal more to investors looking for reasonable pricing than to those seeking high near-term expansion.
Unlock Full ALGN Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete five-pillar UQS Score breakdown
- ✓Access detailed financial metrics and trend data
- ✓Compare ALGN against sector peers side by side
- ✓Track pillar changes across reporting periods
- ✓Screen for stocks with similar risk and valuation profiles
- ✓Get the full analyst-grade view in one place
Pro Analysis
ALGN — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 58.0 | 59.3 | 54.0 | 29.7 | 84.8 | 73.5 | -0.2 |
| May 22, 2026 | 58.2 | 59.3 | 54.0 | 29.7 | 84.8 | 74.5 | -0.3 |
| May 21, 2026 | 58.5 | 59.9 | 54.0 | 29.7 | 84.8 | 75.8 | -0.3 |
| May 20, 2026 | 58.8 | 59.9 | 54.0 | 29.7 | 84.8 | 77.6 | +0.4 |
| May 19, 2026 | 58.4 | 59.7 | 54.0 | 29.7 | 84.8 | 75.6 | -0.1 |
| May 17, 2026 | 58.5 | 59.7 | 54.0 | 29.7 | 84.8 | 75.9 | -0.1 |
| May 16, 2026 | 58.6 | 59.7 | 54.0 | 29.7 | 84.8 | 76.8 | +0.1 |
| May 15, 2026 | 58.5 | 59.4 | 54.0 | 29.7 | 84.8 | 76.9 | 0.0 |
| May 14, 2026 | 58.5 | 59.4 | 54.0 | 29.7 | 84.8 | 76.6 | 0.0 |
| May 13, 2026 | 58.5 | 59.2 | 54.0 | 29.7 | 84.8 | 77.2 | -0.1 |
ALGN — Pillar Breakdown
Quality
— 59.3/100 (25%)Align Technology, Inc. shows solid profitability with healthy returns on capital and reasonable margins.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 29.7/100 (20%)Align Technology, Inc. faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 84.8/100 (15%)Align Technology, Inc. carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 74.5/100 (15%)Align Technology, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 54/100 (25%)Align Technology, Inc. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ALGN.
Score Composition
Financial Data
More Stock Analysis
How is the ALGN UQS Score Calculated?
The UQS (Unified Quality Score) for Align Technology, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Align Technology, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Align Technology, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.